EIF4E and breast cancer: Consistent with the patient data, western blot analysis showed that doxorubicin, cyclophosphamide and fluorouracil time-dependently increased eIF4E phosphorylation at Ser209 in several breast cancer cell lines, including MCF-7, MDA-MB-231, SKBR-3 cells (Figure 3).